患有早期慢性肝病的儿童的学校准备:英格兰基于人口的链接数据队列
Nicolás R Libuy1,2, Marianne Samyn3, Katie L Harron4
1School of Government, Universidad Adolfo Ibanez, Santiago, Chile.
Archives of disease in childhood
|February 16, 2026
概括
患有早期慢性肝病 (CLD) 的儿童的学业准备明显降低. 这种早期发病的肝病带来了更大的认知风险,影响了所有领域的发展.
科学领域:
- 儿科健康 儿科健康
- 发育儿科 发育儿科
- 公共卫生 公共卫生
背景情况:
- 慢性肝病 (CLD) 影响儿童,之前的证据表明与较低的认知能力有关.
- 早期开始的CLD对学校准备能力的影响仍然没有得到充分的研究.
研究的目的:
- 研究在5岁之前诊断的早期慢性肝病 (CLD) 与5岁时的学业准备之间的关联.
主要方法:
- 一项以人口为基础的队列研究利用了英格兰的相关健康和教育数据.
- 包括2002-2012年出生的儿童,在4-5岁时获得教师评估.
- 通过ICD-10和医院代码识别的CLD诊断;多变量回归分析了发展结果.
主要成果:
- 在超过500万名学生中,0.1%的学生在5岁时患有早期开始的CLD.
- 患有CLD的儿童不太可能实现良好的发育 (55.8%vs35.3%),并且标准化得分较低.
- 在所有发育领域观察到负面影响,特别是身体发育,对女孩和严重病例的影响更大.
结论:
- 与同龄人相比,早期出现的CLD与增加的认知风险和较差的学校准备程度有关.
- 需要进一步研究纵向教育成果和特定的CLD相关因素.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
212
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
212
Esophageal Varices-II: Clinical Features and Management
626
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
626
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
258
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
258
Learning Disabilities
643
Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
Dyslexia
Dyslexia is a...
643
Diseases of the Liver and Gallbladder
2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism
257
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
257


